Advertisement rdharma@digitalinsightresearch.in, Author at Pharmaceutical Business review - Page 17 of 37
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

GSK closes acquisition of Tesaro for $5.1bn

Tesaro acquisition will enable GSK to strengthen its pharmaceutical business; and expand its pipeline and commercial capability in oncology. Tesaro president and COO Dr Mary Lynne Hedley said: